Rapid parallel blood typing on centrifugal microfluidic platform by microcolumn gel immunoassay

Area of Science:

• Clinical diagnostics
• Immunoassays
• Microfluidics

Background:

• Traditional microcolumn gel immunoassay (MGIA) offers reliable sensitivity and accuracy for clinical diagnosis.
• Limitations of traditional MGIA include poor portability, low throughput, and long analysis times.

Purpose of the Study:

• To develop a centrifugal microfluidic-based microcolumn gel immunoassay (μMGIA) platform.
• To address the limitations of traditional MGIA for clinical blood typing.

Main Methods:

• Integration of microfluidic technology with MGIA.
• Development of a centrifugal platform for automated immunoassay processes.
• Application of the μMGIA platform for blood typing of clinical samples.

Main Results:

• The μMGIA platform can simultaneously detect six blood group antigens in five clinical blood samples within 2 minutes.
• Achieved 100% accuracy in detecting ABO and Rh blood group antigens.
• Outperformed the traditional slide method in terms of speed and efficiency.

Conclusions:

• The μMGIA platform overcomes the limitations of traditional MGIA, offering enhanced portability, throughput, and speed.
• This microfluidic-integrated immunoassay provides a novel and efficient approach for clinical blood typing.
• The μMGIA platform represents a significant advancement in immunoanalysis for clinical applications.